Back
SpringWorks Therapeutics Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
SWTX
SpringWorks Therapeutics
Last Price:
$47.44
Seasonality Move:
-1.61%
7 Day Trial
ALL ACCESS PASS
$
7

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bearish and SWTX is experiencing slight buying pressure.
SpringWorks Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.79 | Sell |
20-day SMA: | 50.51 | Sell |
50-day SMA: | 46.55 | Buy |
200-day SMA: | 39.03 | Buy |
8-day EMA: | 48.48 | Sell |
20-day EMA: | 49.58 | Sell |
50-day EMA: | 47.38 | Buy |
200-day EMA: | 41.08 | Buy |
SpringWorks Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.32 | Sell |
Relative Strength Index (14 RSI): | 44.67 | Sell |
Chaikin Money Flow: | 444735 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.33 - 55.05) | Sell |
Bollinger Bands (100): | (33.83 - 49.87) | Buy |
SpringWorks Therapeutics Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 47.49 while SWTX 8-day simple moving average is 48.79, which is a Sell signal.
-
The stock price of SWTX is 47.49 while SpringWorks Therapeutics 20-day SMA is 50.51, which makes it a Sell.
-
SpringWorks Therapeutics 50-day simple moving average is 46.55 while SWTX share price is 47.49, making it a Buy technically.
-
SWTX stock price is 47.49 and SpringWorks Therapeutics 200-day simple moving average is 39.03, creating a Buy signal.
SWTX Technical Analysis vs Fundamental Analysis
Sell
34
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a SellThe current SpringWorks Therapeutics [SWTX] share price is $47.49. The Score for SWTX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
3.6B
Price in USD:
47.49
Share Volume:
995.4K
SpringWorks Therapeutics 52-Week Range
52-Week High:
62.00
52-Week Low:
28.21
Sell
34
SpringWorks Therapeutics (SWTX)
is a Sell
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?The SpringWorks Therapeutics stock price is 47.49 USD today.
-
Will SWTX stock go up or go down?SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is SpringWorks Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is overvalued.
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 47.49 while SWTX 8-day exponential moving average is 48.48, which is a Sell signal.
-
The stock price of SWTX is 47.49 while SpringWorks Therapeutics 20-day EMA is 49.58, which makes it a Sell.
-
SpringWorks Therapeutics 50-day exponential moving average is 47.38 while SWTX share price is 47.49, making it a Buy technically.
-
SWTX stock price is 47.49 and SpringWorks Therapeutics 200-day simple moving average is 41.08, creating a Buy signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
-
SWTX Moving Average Covergence Divergence (MACD) indicator is -0.32, suggesting SpringWorks Therapeutics is a Sell
-
SpringWorks Therapeutics Relative Strength Index (RSI) is 44.67, which suggest SpringWorks Therapeutics is oversold
-
The Bollinger Bands (25) for SpringWorks Therapeutics is (48.33 - 55.05), which suggest SpringWorks Therapeutics is a Buy
-
The Bollinger Bands (100) for SpringWorks Therapeutics is (33.83 - 49.87), which suggest SpringWorks Therapeutics is a Buy
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.